Human apolipoproteins A-I and A-II in cell cholesterol efflux - Studies with transgenic mice

被引:43
|
作者
Chiesa, G
Parolini, C
Canavesi, M
Colombo, N
Sirtori, CR
Fumagalli, R
Franceschini, G
Bernini, F
机构
[1] Univ Parma, Inst Pharmacol & Pharmacognosy, I-43100 Parma, Italy
[2] Univ Milan, Inst Pharmacol Sci, Milan, Italy
[3] Univ Milan, Ctr E Grossi Paoletti, Milan, Italy
关键词
reverse cholesterol transport; HDL; tissue culture cells; phospholipids; atherosclerosis;
D O I
10.1161/01.ATV.18.9.1417
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The first step in reverse cholesterol transport is the movement of cholesterol out of cells onto lipoprotein accepters in the interstitial fluid. The contribution of specific lipoprotein components to this process remains to be established. In this study, the role of human apolipoproteins (apo) A-I and A-II in the efflux of cellular cholesterol was investigated in transgenic mouse models in which the expression of murine apoA-I was abolished due to gene targeting (A-IKO). Serum from A-IKO mice and from mice expressing human apoA-I and/or human apoA-II was incubated with [H-3]cholesterol-labeled Fu5AH rat hepatoma cells for 4 hours at 37 degrees C. The cholesterol efflux to the serum of A-IKO mice was markedly lower than that to the serum of mice transgenic for human apoA-I (5.0+/-1.5% versus 25.0+/-4.0%). Expression of human apoA-II alone did not modify the cholesterol efflux capacity of A-IKO mouse serum. Cholesterol efflux to serum of mice expressing human apoA-II together with human apoA-I was significantly lower than that to human apoA-I mouse serum (20.0+/-12.3% versus 25.0+/-4.0%). Regression analysis of cholesterol efflux versus the lipid/apolipoprotein concentrations of mouse serum suggested that 3 independent factors contribute to determine the cholesterol efflux potential of serum: the apolipoprotein composition of HDL, the serum concentration of HDL phospholipids, and the presence of a small fraction of particles containing apoA-I.
引用
收藏
页码:1417 / 1423
页数:7
相关论文
共 50 条
  • [21] THE SURFACE-PROPERTIES OF APOLIPOPROTEINS A-I AND A-II AT THE LIPID WATER INTERFACE
    IBDAH, JA
    KREBS, KE
    PHILLIPS, MC
    BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 1004 (03) : 300 - 308
  • [22] DIFFERENT KINETIC FATES OF APOLIPOPROTEINS A-I AND A-II FROM LYMPH CHYLOMICRA
    PARKS, J
    RUDEL, L
    CIRCULATION, 1979, 60 (04) : 118 - 118
  • [23] EVIDENCE FOR RECIRCULATION OF APOLIPOPROTEINS A-I AND A-II BETWEEN PLASMA AND HUMAN THORACIC-DUCT LYMPH
    ANDERSON, DW
    BRONZERT, TJ
    SCHAEFER, EJ
    NIBLACK, GD
    ZECH, L
    FORTE, T
    BREWER, HB
    CLINICAL RESEARCH, 1979, 27 (02): : A362 - A362
  • [24] APOLIPOPROTEINS (A-I, A-II, B), LP(A) LIPOPROTEIN AND LECITHIN-CHOLESTEROL ACYLTRANSFERASE ACTIVITY IN DIABETES-MELLITUS
    SCHERNTHANER, G
    KOSTNER, GM
    DIEPLINGER, H
    PRAGER, R
    MUHLHAUSER, I
    ATHEROSCLEROSIS, 1983, 49 (03) : 277 - 293
  • [25] Apolipoprotein A-II Increases Cholesterol Efflux Capacity Of HDL Via The Apolipoprotein A-I C-terminus
    Morris, Jamie C.
    Sexmith, Hannah
    Street, Scott E.
    Melchior, John T.
    Shah, Amy S.
    Davidson, William
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2024, 44
  • [26] Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis
    McComb, Mason
    Krikheli, Maggie
    Uher, Tomas
    Browne, Richard W.
    Srpova, Barbora
    Oechtering, Johanna
    Maceski, Aleksandra Maleska
    Tyblova, Michaela
    Jakimovski, Dejan
    Ramasamy, Deepa P.
    Bergsland, Niels
    Krasensky, Jan
    Noskova, Libuse
    Fialova, Lenka
    Weinstock-Guttman, Bianca
    Havrdova, Eva Kubala
    Vaneckova, Manuela
    Zivadinov, Robert
    Horakova, Dana
    Kuhle, Jens
    Ramanathan, Murali
    JOURNAL OF CLINICAL LIPIDOLOGY, 2020, 14 (05) : 675 - +
  • [27] CAPILLARY GEL-ELECTROPHORESIS ANALYSIS OF APOLIPOPROTEINS A-I AND A-II IN HUMAN HIGH-DENSITY-LIPOPROTEINS
    GOUX, A
    ATHIAS, A
    PERSEGOL, L
    LAGROST, L
    GAMBERT, P
    LALLEMANT, C
    ANALYTICAL BIOCHEMISTRY, 1994, 218 (02) : 320 - 324
  • [28] EFFECT OF LONG-TERM ANTIHYPERTENSIVE AND HYPOLIPIDEMIC TREATMENT ON HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND APOLIPOPROTEINS A-I AND A-II
    MIETTINEN, TA
    HUTTUNEN, JK
    EHNHOLM, C
    KUMLIN, T
    MATTILA, S
    NAUKKARINEN, V
    ATHEROSCLEROSIS, 1980, 36 (02) : 249 - 259
  • [29] Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin:cholesterol acyltransferase
    Clay, MA
    Pyle, DH
    Rye, KA
    Barter, PJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) : 9019 - 9025
  • [30] CHOLESTEROL BINDING TO APOLIPOPROTEINS A-I AND E
    KLIMOV, AN
    KOZHEVNIKOVA, KA
    KLYUEVA, NN
    BELOVA, EV
    BIOCHEMISTRY-MOSCOW, 1992, 57 (04) : 378 - 386